344 Transgenic Expression of CD40 Ligand (CD40L) Produces an In Vivo Antitumor Immune Response Against Both CD40 Positive and Negative Plasmacytoma Cells Molecular Therapy Vol 5, No 5, May 2002, Part[.]
NON-VIRAL IMMUNOTHERAPY #D =&H -M8,I O 998/ " " G " './ ? & 6 ? #D. & 6 3 ?"2;8 1 >D(' & 6 ?'( S114 8 2;8 ? #D. ?γ $B6 D'"6 ?"Cγ8 3 & 6 ' ?"2;8 " E 3 ?"2;8 ? >'. #D. ?"2;8 ?" ?"2;8 ?" 344 T ransgenic Expression of CD40-Ligand (CD40L) Transgenic Produces an In Vivo Antitumor Immune Response Against Both CD40 Positive and Negative Plasmacytoma Cells Gianpietro Dotti,1 Barbara Savoldo,1 Patricia Yotnda,1 Donna Rill,1 Malcolm Brenner.1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States ( % 2 # # -##/ 0 3 " -2;"8%$:9 2;",%$:B/ 3 4" " 3 $69D 3 2" 3 $69 " " $69D 3 -'!/ - / $69-"/ 3 3 $69D -#!"88 (89;/ 3 $69 -F",6/- $ ( @ * / 3 -D;8/ 8$69D $69D $*' $69D 3 $69D 3 2'D2%2+